IMAGE: Lung squamous cell carcinoma

Breaking News

Key: Meeting M      Journal J      Funder F

Showing releases 26-50 out of 1341.

<< < 1 | 2 | 3 | 4 | 5 | 6 > >>

Public Release: 25-May-2016
Health Technology Assessment
Lung cancer survival rate increases by 73 percent if caught early
The UK Lung cancer screening trial has been successfully completed and demonstrated that patients with a high risk of developing lung cancer can be identified with early stage disease and have up to a 73 percent chance of surviving for five years or more. The UKLS trial was conducted by experts in the University of Liverpool.

Contact: Simon Wood
simon.wood@liverpool.ac.uk
44-151-794-8356
University of Liverpool

Public Release: 25-May-2016
171st Meeting of the Acoustical Society of America
Dialing up chemotherapy for pancreatic cancer with ultrasound
Researchers at Haukeland University Hospital in Bergen, Norway have combined a laboratory ultrasound technique called 'sonoporation' with the commercially-available chemotherapy compound Gemcitabine to increase the porosity of pancreatic cells with microbubbles and to help get the drug into cancer cells where it is needed. They report some initial results at this week's ASA's 171st meeting in Salt Lake City.

Contact: AIP Media Line
media@aip.org
301-209-3090
Acoustical Society of America

Public Release: 25-May-2016
Science Translational Medicine
Scientists block breast cancer cells from hiding in bones
Scientists at the Duke Cancer Institute have identified a molecular key that breast cancer cells use to invade bone marrow in mice, where they may be protected from chemotherapy or hormonal therapies that could otherwise eradicate them. Through years of experiments in mice, the scientists have found ways to outmaneuver this stealth tactic by not only preventing breast cancer cells from entering the bone marrow, but also by flushing cancer cells out into the blood stream where they could be targeted for destruction.
American Society of Clinical Oncology, University of Chicago Breast Cancer Specialized Program of Research Excellence, Duke Cancer Institute

Contact: Samiha Khanna
samiha.khanna@duke.edu
919-419-5069
Duke University Medical Center

Public Release: 25-May-2016
JAMA Cardiology
Study finds elevated cancer risk among women with new-onset atrial fibrillation
Among nearly 35,000 initially healthy women who were followed-up for about 20 years, those with new-onset atrial fibrillation had an increased risk of cancer, according to a study published online by JAMA Cardiology.

Contact: David Conen
david.conen@usb.ch
The JAMA Network Journals

Public Release: 25-May-2016
Neurology
Researchers identify immune genes tied to common, deadly brain cancer
Researchers have identified a group of immune system genes that may play a role in how long people can live after developing a common type of brain cancer called glioblastoma multiforme, a tumor of the glial cells in the brain. The research is published in the May 25, 2016, online issue of Neurology, the medical journal of the American Academy of Neurology.

Contact: Rachel Seroka
rseroka@aan.com
612-928-6129
American Academy of Neurology

Public Release: 24-May-2016
Cancer Prevention Research
MD Anderson study uncovers early genetic changes in premalignant colorectal tissue
Researchers at The University of Texas MD Anderson Cancer Center have discovered mutations that may fuel early cancer growth in precancerous colorectal tissue from high-risk patients.

Contact: Clayton R. Boldt
crboldt@mdanderson.org
713-792-9518
University of Texas M. D. Anderson Cancer Center

Public Release: 24-May-2016
American Society of Clinical Oncology
Exercise, future anticancer therapy?
First international clinical trial evaluating the effect of intense physical exercise to improve survival of men with advanced prostate cancer.
Movember Foundation

Contact: Isabelle Girard
isabelle.girard.chum@ssss.gouv.qc.ca
51-489-080-001-272
University of Montreal Hospital Research Centre (CRCHUM)

Public Release: 24-May-2016
Digestive Disease Week
Colorectal cancer rate rising among younger people
A new study shows the rate of colorectal cancer (CRC) continues to increase in individuals under 50 years old, despite the fact that the overall rate of the disease has been declining in recent years. Following examination of more than 1 million CRC patient records over 10 years, researchers suggested that health-care providers should be more vigilant about detecting symptoms in younger patients. The findings were presented at Digestive Disease Week®.

Contact: Aimee Frank
newsroom@gastro.org
301-941-2620
Digestive Disease Week

Public Release: 24-May-2016
International Journal of Epidemiology
Living near a landfill could damage your health
According to research published today in the International Journal of Epidemiology, health is at risk for those who live within five kilometres of a landfill site.
Lazio Waste General Directorate

Contact: Chloe Foster
chloe.foster@oup.com
186-535-3584
Oxford University Press

Public Release: 24-May-2016
Nature Communications
Cell Labelling via Photobleaching: A precious ally for scientific research
A multidisciplinary team of researchers gives birth to a unique method that enables instant, specific labeling of individual cells, Cell Labelling via Photobleaching (CLaP). This method will become a precious ally in a wide range of scientific research, with particular applications for genomics.
Natural Sciences and Engineering Research Council of Canada, Fonds de recherché santé du Québec, Canadian Institutes of Health Research, Genome Canada, FROUM

Contact: Julie Gazaille
j.cordeau-gazaille@umontreal.ca
514-343-6796
University of Montreal

Public Release: 24-May-2016
Cancer Prevention Research
Sequencing analysis identifies genomic alterations in colorectal precancers
Whole-exome sequencing of both colorectal adenomas (precancers often called polyps) and intestinal mucosa at risk for developing into adenomas from patients with familial adenomatous polyposis (FAP) has generated a comprehensive picture of the genomic alterations that characterize the evolution of normal mucosa to precancer.
National Institutes of Health, MD Anderson Cancer Center Institutional Research Grant Program, Feinberg family, Janice Davis Gordon Memorial in Colorectal Cancer Prevention Research, Schissler Foundation, Spanish Ministry of Economy and Competitiveness

Contact: Lauren Riley
lauren.riley@aacr.org
215-446-7155
American Association for Cancer Research

Public Release: 24-May-2016
Nature Communications
Research points to possible new prevention strategies for ovarian cancer
The discovery of early changes in the cells of the Fallopian tubes of women carrying the BRCA genetic mutation could open the way for new preventative strategies for ovarian cancer, reducing the need for invasive surgery, according to research published today in science journal Nature Communications.

Contact: Wesley Hutchins
Wesley.Hutchins@eveappeal.org.uk
020-760-50108
University College London

Public Release: 24-May-2016
Society for Surgery of the Alimentary Tract Annual Meeting
Chemo, radiation, surgery combo boosts survival for pancreatic cancer patients
In roughly one-third of pancreatic cancer patients, tumors have grown around the pancreas to encompass critical blood vessels. Conventional wisdom has long held that surgery to remove the tumors is rarely an option, and life expectancies are usually measured in months.

Contact: Sharon Theimer
newsbureau@mayo.edu
507-284-5005
Mayo Clinic

Public Release: 24-May-2016
INNOCOS World Beauty Innovation Summit
Aging
Deep learning enters the beauty industry
Insilico Medicine will present their results in applying deep learning to biomarker development and cosmetics applications at the INNOCOS World Beauty Innovation Summit in Vienna June 9-10.

Contact: Qingsong Zhu
zhu@insilicomedicine.com
443-451-7212
InSilico Medicine, Inc.

Public Release: 24-May-2016
Journal of Pathology
Vitamin A may help improve pancreatic cancer chemotherapy
The addition of high doses of a form of vitamin A could help make chemotherapy more successful in treating pancreatic cancer, according to an early study by Queen Mary University of London. The promising initial results have led to the potential treatment being tested in a new clinical trial.
Engineering and Physical Sciences Research Council's Knowledge Transfer Network, Pancreatic Cancer Research Fund, Cancer Research UK, Barts Charity

Contact: Joel Winston
j.winston@qmul.ac.uk
44-207-882-7943
Queen Mary University of London

Public Release: 24-May-2016
2016 Asia Pacific Lung Cancer Conference (APLCC)
APLCC 2016 calls on Asian-Pacific governments to help reduce lung cancer deaths
The biennial Asia Pacific Lung Cancer Conference was successfully organized in Chiang Mai, Thailand, by the International Association for the Study of Lung Cancer, and others. More than 870 participants from 26 countries with a wide range of expertise spanning prevention, treatment, research, and care and support fields actively participated in this regional meeting.

Contact: Jeff Wolf
Jeff.Wolf@iaslc.org
720-325-2952
International Association for the Study of Lung Cancer

Public Release: 24-May-2016
PLOS Genetics
May repairs full of mistakes develop into cancer?
A group of researchers at Osaka University found that if DNA damage response does not work when DNA is damaged by radiation, proteins which should be removed remain instead, and a loss of genetic information can be incited, which, when repaired incorrectly, will lead to the tumor formation.
Japan Society for the Promotion of Science, Ministry of Education, Culture, Sports, Science and Technology of Japan

Contact: Saori Obayashi
saori_obayashi@mail.osaka-u.ac.jp
81-661-055-886
Osaka University

Public Release: 24-May-2016
Nature Medicine
Targeted treatment for liver cancer under way
Researchers at the University of Eastern Finland and Eberhard Karls Universität Tübingen have discovered a new molecular mechanism that can be used to inhibit the growth of hepatocellular carcinoma, which is the most common liver cancer. The findings were published in Nature Medicine.
Academy of Finland, EU, Deutsche Forschungsgemeinschaft

Contact: Antti Poso
antti.poso@uef.fi
358-403-552-462
University of Eastern Finland

Public Release: 23-May-2016
Chemistry - A European Journal
Rice University lab simplifies total synthesis of anti-cancer agent
Rice University researchers reported the streamlined total synthesis of delta12-prostaglandin J3, a molecule that has been reported as killing leukemic cancer cells. The work has led to the production of numerous designed synthetic derivatives that show even greater potential for fighting many forms of cancer.
National Institutes of Health, Cancer Prevention and Research Institute of Texas, Welch Foundation

Contact: David Ruth
david@rice.edu
713-348-6327
Rice University

Public Release: 23-May-2016
Journal of Medicinal Chemistry
Breast cancer drug discovery offers hope of new treatments
A new drug discovery approach has yielded a potential therapy for breast cancer that may be more effective than existing medicines. Scientists at the University of Edinburgh have identified a chemical compound that is highly effective at blocking the growth of breast cancer cells in the laboratory.

Contact: Jen Middleton
jen.middleton@ed.ac.uk
44-779-564-0662
University of Edinburgh

Public Release: 23-May-2016
Clinical Cancer Research
Proteins key to unlocking cancer for National Cancer Moonshot
The National Cancer Moonshot initiative needs to move beyond genomics to target the proteins that are driving cancer, according to an Inova Health System and George Mason University collaborative paper published Thursday in the American Association for Cancer Research.

Contact: Michele McDonald
mmcdon15@gmu.edu
703-993-8781
George Mason University

Public Release: 23-May-2016
International Journal of Molecular Sciences
Study finds breast and ovarian cancer may have similar origins
While breast cancer is the most common cause of cancer death in women worldwide, ovarian cancer also is a significant source of mortality as the fifth leading cause of cancer death among women. These facts reflect the continued need for further understanding and innovation in cancer treatment. A new study published in the International Journal of Molecular Sciences, describes a new concept of how these two cancers may evolve in a similar way and may eventually lead to more effective therapies for both.
American Cancer Society

Contact: Kristen Perfetuo
kristenp@bu.edu
617-638-8484
Boston University Medical Center

Public Release: 23-May-2016
Journal of Thoracic Oncology
Consensus statement on optimizing management of EGFR mutation positive NSCLC patients
The International Association for the Study of Lung Cancer (IASLC) created the 2016 consensus statement on optimizing management of epidermal growth factor receptor (EGFR) mutation positive (M+) non-small cell lung cancer (NSCLC) patients to discuss key pathologic, diagnostic, and therapeutic considerations. The statement also makes recommendations for clinical guidance and research priorities, such as optimal choice of EGFR tyrosine kinase inhibitors, management of brain metastasis, role of re-biopsies, and use of circulating free DNA for molecular studies.

Contact: Jeff Wolf
Jeff.Wolf@iaslc.org
720-325-2952
International Association for the Study of Lung Cancer

Public Release: 23-May-2016
American Association for Cancer Research annual meeting
Purdue research may expand engineered T-cell cancer treatment
Researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue. The scientists designed genetically engineered CAR T cells that must be activated and targeted by a small molecule adaptor. The technology has been tested in animal models. A poster presentation describing the work was presented at the American Association for Cancer Research annual meeting in New Orleans.
Endocyte Inc.

Contact: Elizabeth Gardner
ekgardner@purdue.edu
765-494-2081
Purdue University

Public Release: 23-May-2016
Breast Cancer Research and Treatment
Sylvester researchers identify novel treatment for aggressive form of breast cancer
A recent study by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine revealed that triple-negative breast cancer, which has generally been unresponsive to hormone receptor-targeted treatments, can indeed be treated using vitamin D and androgen receptor-targeted therapy.

Contact: Patrick Bartosch
patrick.bartosch@med.miami.edu
305-243-8219
University of Miami Miller School of Medicine

Showing releases 26-50 out of 1341.

<< < 1 | 2 | 3 | 4 | 5 | 6 > >>

  Search News Releases

     

 

EurekAlert!